Chargement en cours...
Newer agents in antiplatelet therapy: a review
Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in pathophysiological conditions such as myocardial infarction, ischemia, and stroke. Although there has been significant advancement in antiplatelet therapeutic approaches, aspirin still remains the gold standard t...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3393068/ https://ncbi.nlm.nih.gov/pubmed/22792011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S25421 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|